Heparin-Induced Thrombocytopenia

Jan 1, 2019 by in ONCOLOGY Comments Off on Heparin-Induced Thrombocytopenia

SUMMARY Print Section Listen SUMMARY Heparin-induced thrombocytopenia (HIT) is a prothrombotic complication of treatment with heparin. It is associated with mild-to-moderate thrombocytopenia, although the main clinical concern is the high…

read more

Control of Coagulation Reactions

Jan 1, 2019 by in ONCOLOGY Comments Off on Control of Coagulation Reactions

SUMMARY Print Section Listen SUMMARY The blood coagulation system, like a powerful idling engine, is always active and generating thrombin at very low levels, poised for explosive thrombin generation. Positive…

read more

Vascular Function in Hemostasis

Jan 1, 2019 by in ONCOLOGY Comments Off on Vascular Function in Hemostasis

SUMMARY Print Section Listen SUMMARY Blood vessels, especially their endothelial lining, play a critical role in the maintenance of vascular fluidity, arrest of hemorrhage (hemostasis), prevention of occlusive vascular phenomena…

read more

Megakaryopoiesis and Thrombopoiesis

Jan 1, 2019 by in ONCOLOGY Comments Off on Megakaryopoiesis and Thrombopoiesis

SUMMARY Print Section Listen SUMMARY Each day the adult human produces approximately 1 × 1011 platelets, a level of production that can increase 10- to 20-fold in times of increased…

read more

Reactive Thrombocytosis

Jan 1, 2019 by in ONCOLOGY Comments Off on Reactive Thrombocytosis

SUMMARY Print Section Listen SUMMARY The three major pathophysiologic causes of thrombocytosis are (1) clonal, including essential (or primary) thrombocythemia and other myeloproliferative neoplasms; (2) familial, including rare cases of…

read more
Get Clinical Tree app for offline access